Skip to main content

梅毒テスト市場：将来の予測は印象的な成長率を示しています

 


Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results - thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.

The global syphilis testing market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the period 2014-2020. The secondary syphilis testing would continue to be the largest market segment through 2020.Latin America, Middle East & Africa (LAMEA) market accounted for about 43% revenue share of the syphilis testing market in 2014.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/675

LAMEA and Asia Pacificconstitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions.

The Major Key Players Are:

·        Roche Diagnostics

·        Hologic, Inc.

·        Becton Dickinson & Company

·        Abbott Laboratories

·        BioMerieux

·        Alere Inc.

·        Cepheid Inc.

·        Affymetrix, Inc.

·        Diasorin.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/675

Key findings of Syphilis Testing Market:

  • LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period
  • United states remains a major market in the North Americasyphilis testing market through 2020
  • Spainand Germanycollectively accounts for about one fourth of the Europesyphilis testing market
  • ChinaandIndiacollectively accounts for about 89% share in theAsia Pacificsyphilis testing market

Access Full Report @ https://www.alliedmarketresearch.com/syphilis-testing-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Labels:

Comments

Post a Comment

Popular posts from this blog

放射線情報システム市場 is expected to reach $941 million by 2022, supported by a CAGR of 5.9%

T he radiology information system market was valued at  $603 million  in 2015, and is projected to reach  $941 million  by 2022, growing at a CAGR of 5.9% from 2016 to 2022. The integrated radiology information systems segment held over three-fifths share of the total market in 2015. Radiology information system (RIS) is a computer networked system used to organize and manage the workflow of medical imagery and radiology department, supporting business analysis in a department. RIS is widely used along with picture archiving and communication system (PACS) and vendor neutral archive to manage billing, record keeping, and image archives. The integrated radiology information systems held the largest share in 2015 and is expected to grow at the highest CAGR of 6.0% during the analysis period. This is owing to the surging adoption and demand of integrated healthcare information technology platforms in various healthcare organization for easy operations to curb over expe...
Post a Comment
Read more

2027年までに9億8,330万ドルを獲得する心臓再同期療法市場

As per the report published by Allied Market Research, the   Cardiac Resynchronization Therapy Market   was pegged at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, growing at a CAGR of 4.9% from 2020 to 2027. Download Sample Report at:  https://www.alliedmarketresearch.com/request-sample/10657 Rise in the geriatric population, increase in the prevalence of cardiovascular diseases, and development in healthcare infrastructure have boosted the growth of the U.S. cardiac resynchronization therapy market. Moreover, high-end technological developments in CRT devices supplemented the market growth. However, product recalls in the U.S., cost of CRT devices, and shortage of healthcare professionals hinder the market growth. On the contrary, developing opportunities in the low economic U.S. states would open lucrative opportunities for the market players. Covid-19 scenario- The integration of CRT pacemaker and cardiac resynchronization therapy defibrill...
Post a Comment
Read more

組織工学市場 to Reach $6.81 Billion by 2027: Allied Market Research

As per the report published by Allied Market Research, the global  Tissue Engineering Market  generated $2.37 billion in 2019, and is projected to garner $6.81 billion by 2027, growing at a CAGR of 14.2% from 2020 to 2027. Rise in need for tissue engineering in organ transplantation, surge in prevalence of chronic diseases and trauma emergencies, and advancements in medical equipment technologies drive the growth of the global tissue engineering market. However, high cost associated with tissue engineered products hampers the market growth. On the contrary, untapped opportunities in the developing markets is expected to create lucrative opportunities in the future. Download Detailed COVID-19 Impact Sample Report at:  https://www.alliedmarketresearch.com/request-for-customization/4323?reqfor=covid Covid-19 scenario: Since the Covid-19 outbreak, clinical research in tissue engineering is temporarily suspended and the funds are redirected for clinical trials for the Covid-1...
Post a Comment
Read more